In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in electively irradiated lymph nodes among patients with ...

SHREVEPORT, La. - A new landmark study published in The Lancet is changing how doctors treat certain head and neck cancers.

Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...

Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...

MSK radiation oncologist Dr. Nancy Lee helped design the clinical trial showing that immunotherapy given around surgery could reduce recurrence of some head and neck cancers. A phase 3 clinical trial ...

The IAEA has launched a new two-year coordinated research project to explore how artificial intelligence can assist with contouring — a crucial step in cancer treatment, in which a tumour and the ...

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...